LicianPro

Gain Therapeutics, Inc. ·

GANX 8-K 2026-10-01

Gain Therapeutics, Inc. (GANX) 8-K dated 2026-10-01 — accession 0001104659-26-112624.

Gain Therapeutics, Inc. (GANX) is a biotechnology company listed on US.

Gain Therapeutics, Inc. filed a 8-K on 2026-10-01. Accession 0001104659-26-112624.

This 8-K covers: Other events (Item 8.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported GANX revenue for 2023-09-30 was $55.2K. Net income was -$4.7M. Revenue was up 0.0% from 2023-06-30 to 2023-09-30. GANX currently screens at market cap $53.0M.

Not investment advice. The GANX SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr